Vetmedin Rx is for the treatment of congestive heart failure in dogs. As the first of a new class of heart treatments termed Inodilators, Vetmedin has been shown to significantly improve the clinical signs and extend the life expectancy in dogs with congestive heart failure. Vetmedin works through two complementary modes of action; it opens up the blood vessels taking blood to and away from the heart, thereby lowering the pressure on the heart and reducing the work the heart has to do to pump blood around the dog's body. At the same time, Vetmedin® has a direct effect on the heart muscle, helping it to beat stronger and pump blood more efficiently.
Vetmedin (pimobendan) is supplied as oblong capsule containing 2.5 mg pimobendan per tablet. Pimobendan, a benzimidazole-pyridazinone derivative, is a non-sympathomimetic, non-glycoside inotropic drug with vasodilatative properties. Pimobendan exerts a stimulatory myocardial effect by a dual mechanism of action consisting of an increase in calcium sensitivity of cardiac myofilaments and inhibition of phosphodiesterase (Type III). Pimobendan exhibits vasodilating activity by inhibiting phosphodiesterase III activity.
Prescription items are NON-RETURNABLE and NON-REFUNDABLE.
Vetmedin Capsules have been temporarily authorized due to the shortage in the supply of Vetmedin Chewable tablets. Vetmedin Capsules are produced by Boehringer Ingelheim and the FDA is allowing temporary use of it. A new prescription authorization would be required.